BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 2318961)

  • 1. Common low-density lipoprotein receptor mutations in the French Canadian population.
    Leitersdorf E; Tobin EJ; Davignon J; Hobbs HH
    J Clin Invest; 1990 Apr; 85(4):1014-23. PubMed ID: 2318961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent.
    Wang J; Huff E; Janecka L; Hegele RA
    Hum Mutat; 2001 Oct; 18(4):359. PubMed ID: 11668627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians.
    Bétard C; Kessling AM; Roy M; Chamberland A; Lussier-Cacan S; Davignon J
    Hum Genet; 1992 Mar; 88(5):529-36. PubMed ID: 1348044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine mapping of low-density lipoprotein receptor gene by genetic linkage on chromosome 19p13.1-p13.3 and study of the founder effect of four French Canadian low-density lipoprotein receptor gene mutations.
    Couture P; Morissette J; Gaudet D; Vohl MC; Gagné C; Bergeron J; Després JP; Simard J
    Atherosclerosis; 1999 Mar; 143(1):145-51. PubMed ID: 10208489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Trp23-Stop and Trp66-Gly mutations in the LDL receptor gene: common causes of familial hypercholesterolemia in Denmark.
    Jensen HK; Jensen LG; Hansen PS; Faergeman O; Gregersen N
    Atherosclerosis; 1996 Feb; 120(1-2):57-65. PubMed ID: 8645371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic aspects of familial hypercholesterolemia and its diagnosis.
    Motulsky AG
    Arteriosclerosis; 1989; 9(1 Suppl):I3-7. PubMed ID: 2563220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
    Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
    Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for new mutations in the LDL receptor gene in seven French familial hypercholesterolemia families by the single strand conformation polymorphism method.
    Loux N; Saint-Jore B; Collod G; Dairou F; Benlian P; Truffert J; Dastugue B; Douste-Blazy P; de Gennes JL; Junien C
    Hum Mutat; 1992; 1(4):325-32. PubMed ID: 1301940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of two novel LDL receptor gene defects in French-Canadian pediatric population: mutational analysis and biochemical studies.
    Assouline L; Leitersdorf E; Lambert M; Reshef A; Feoli-Fonseca JC; Levy E
    Hum Mutat; 1997; 9(6):555-62. PubMed ID: 9195230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch population.
    Defesche JC; van Diermen DE; Lansberg PJ; Lamping RJ; Reymer PW; Hayden MR; Kastelein JJ
    Hum Genet; 1993 Dec; 92(6):567-70. PubMed ID: 7903269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners.
    Leitersdorf E; Van der Westhuyzen DR; Coetzee GA; Hobbs HH
    J Clin Invest; 1989 Sep; 84(3):954-61. PubMed ID: 2569482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monogenic primary hypercholesterolaemia in South Africa.
    Rubinsztein DC; van der Westhuyzen DR; Coetzee GA
    S Afr Med J; 1994 Jun; 84(6):339-44. PubMed ID: 7740380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A missense mutation in the low density lipoprotein receptor gene causes familial hypercholesterolemia in Sephardic Jews.
    Leitersdorf E; Reshef A; Meiner V; Dann EJ; Beigel Y; van Roggen FG; van der Westhuyzen DR; Coetzee GA
    Hum Genet; 1993 Mar; 91(2):141-7. PubMed ID: 8462973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia.
    Hobbs HH; Brown MS; Russell DW; Davignon J; Goldstein JL
    N Engl J Med; 1987 Sep; 317(12):734-7. PubMed ID: 3627182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FH Afrikaner-3 LDL receptor mutation results in defective LDL receptors and causes a mild form of familial hypercholesterolemia.
    Graadt van Roggen JF; van der Westhuyzen DR; Coetzee GA; Marais AD; Steyn K; Langenhoven E; Kotze MJ
    Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):765-72. PubMed ID: 7773731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland.
    Koivisto UM; Turtola H; Aalto-Setälä K; Top B; Frants RR; Kovanen PT; Syvänen AC; Kontula K
    J Clin Invest; 1992 Jul; 90(1):219-28. PubMed ID: 1634609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of mutations in the low density lipoprotein (LDL)-receptor gene in patients with homozygous familial hypercholesterolemia, and frequency of these mutations in FH patients in the United Kingdom.
    Webb JC; Sun XM; McCarthy SN; Neuwirth C; Thompson GR; Knight BL; Soutar AK
    J Lipid Res; 1996 Feb; 37(2):368-81. PubMed ID: 9026534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a second "French Canadian" LDL receptor gene deletion and development of a rapid method to detect both deletions.
    Ma YH; Bétard C; Roy M; Davignon J; Kessling AM
    Clin Genet; 1989 Oct; 36(4):219-28. PubMed ID: 2805380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hypercholesterolemia in French-Canadians: taking advantage of the presence of a "founder effect".
    Davignon J; Roy M
    Am J Cardiol; 1993 Sep; 72(10):6D-10D. PubMed ID: 8213499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.